Exome Asset Management LLC
Annual return '25
+12.4%
SPY '25
+17.7%
Alpha
-5.3ptsvs SPY
Invested
$558.5M
Holdings
46
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 98%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$PRAX
PRAXIS PRECISION MEDICINES I
Q4 2025: Exited (was 102.0k shares)
8.2%
02
$COGT
COGENT BIOSCIENCES INC
Q4 2025: Exited (was 443.5k shares)
6.0%
03
$ELVN
ENLIVEN THERAPEUTICS INC
Held since at least Q1 2024
4.9%
04
$IONS
IONIS PHARMACEUTICALS INC
Q4 2025: Exited (was 131.0k shares)
4.7%
05
$XBI
SPDR SERIES TRUST
Held since at least Q1 2024
4.3%
06
$GH
GUARDANT HEALTH INC
Q4 2025: Exited (was 98.2k shares)
4.3%
07
$CYTK
CYTOKINETICS INC
Q4 2025: Exited (was 142.4k shares)
3.8%
08
$LLY
ELI LILLY & CO
Q4 2025: Exited (was 7.9k shares)
3.6%
09
$ALMS
ALUMIS INC
Q4 2025: Exited (was 292.8k shares)
3.5%
10
$BBIO
BRIDGEBIO PHARMA INC
Q4 2025: Exited (was 133.1k shares)
2.8%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 13:19 UTC.